2020

1. Assessment of minimal residual disease by next generation sequencing in peripheral blood as a complementary tool for personalized transplant monitoring in myeloid neoplasms

   Journal of Clinical Medicine, Vol. 9, Núm. 12, pp. 1-20

2. Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design

   PLoS ONE, Vol. 15, Núm. 1

3. Strategy for identification of a potential inherited leukemia predisposition in a 299 patient's cohort with tumor-only sequencing data

   Leukemia Research, Vol. 95